Neurent Medical Funding: $149M Raised, Series C (2026)

Neurent Medical funding overview

Neurent Medical is based in Galway, Ireland. Neurent Medical has raised $149M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in February 2026. The round record for Neurent Medical runs through 2026; nothing later has been disclosed. Investors on record include MVM Partners, Sofinnova Partners, EQT Life Sciences, Atlantic Bridge, Fountain Healthcare Partners, Enterprise Ireland. 6 distinct backers are named across the disclosed rounds.

Neurent Medical at a glance

Total raised: $149M
Latest round: Series C
Latest round date: February 2026
Headquarters: Galway, Ireland
Notable investors: MVM Partners, Sofinnova Partners, EQT Life Sciences, Atlantic Bridge, Fountain Healthcare Partners, Enterprise Ireland

Frequently asked about Neurent Medical funding

How much has Neurent Medical raised?: Neurent Medical has raised $149M in total disclosed funding across the rounds on record.
Who has invested in Neurent Medical?: MVM Partners, Sofinnova Partners, EQT Life Sciences, Atlantic Bridge, Fountain Healthcare Partners, Enterprise Ireland are named among the investors backing Neurent Medical.
What was the latest Neurent Medical funding round?: The most recent disclosed round is a Series C, announced in February 2026.
Where is Neurent Medical based?: Neurent Medical is based in Galway, Ireland.
When did Neurent Medical last raise?: The last disclosed Neurent Medical round closed in February 2026 at Series C.

Neurent Medical totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Galway below to benchmark round size and investor mix.

Neurent Medical Funding: $149M Raised, Series C (2026)

Neurent Medical funding overview

Neurent Medical at a glance

Frequently asked about Neurent Medical funding

Companies related to Neurent Medical (15)

Browse related funding lists (9)